{"id":2152417,"date":"2026-03-26T07:52:16","date_gmt":"2026-03-26T07:52:16","guid":{"rendered":"https:\/\/www.thebusinessdesk.com\/yorkshire\/?p=2152417"},"modified":"2026-03-26T07:52:16","modified_gmt":"2026-03-26T07:52:16","slug":"aptamer-lands-4.3m-backing-as-investors-double-down-on-growth-push","status":"publish","type":"post","link":"https:\/\/www.thebusinessdesk.com\/yorkshire\/news\/2152417-aptamer-lands-4.3m-backing-as-investors-double-down-on-growth-push","title":{"rendered":"Aptamer lands \u00a34.3m backing as investors double down on growth push"},"content":{"rendered":"<div class=\"relative basis-auto flex-col -mb-(--composer-overlap-px) pb-(--composer-overlap-px) [--composer-overlap-px:28px] grow flex\">\n<div class=\"flex flex-col text-sm\">\n<section class=\"text-token-text-primary w-full focus:outline-none [--shadow-height:45px] has-data-writing-block:pointer-events-none has-data-writing-block:-mt-(--shadow-height) has-data-writing-block:pt-(--shadow-height) [&amp;:has([data-writing-block])&gt;*]:pointer-events-auto scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]\" dir=\"auto\" data-turn-id=\"request-WEB:0d5af0c0-4281-4f54-8e9d-f0651b56121f-1\" data-testid=\"conversation-turn-4\" data-scroll-anchor=\"true\" data-turn=\"assistant\">\n<div class=\"text-base my-auto mx-auto pb-10 [--thread-content-margin:var(--thread-content-margin-xs,calc(var(--spacing)*4))] @w-sm\/main:[--thread-content-margin:var(--thread-content-margin-sm,calc(var(--spacing)*6))] @w-lg\/main:[--thread-content-margin:var(--thread-content-margin-lg,calc(var(--spacing)*16))] px-(--thread-content-margin)\">\n<div class=\"[--thread-content-max-width:40rem] @w-lg\/main:[--thread-content-max-width:48rem] mx-auto max-w-(--thread-content-max-width) flex-1 group\/turn-messages focus-visible:outline-hidden relative flex w-full min-w-0 flex-col agent-turn\">\n<div class=\"flex max-w-full flex-col gap-4 grow\">\n<div class=\"min-h-8 text-message relative flex w-full flex-col items-end gap-2 text-start break-words whitespace-normal outline-none keyboard-focused:focus-ring [.text-message+&amp;]:mt-1\" dir=\"auto\" data-message-author-role=\"assistant\" data-message-id=\"e95650d5-2844-4953-bb0a-067f42af1866\" data-message-model-slug=\"gpt-5-3\" data-turn-start-message=\"true\">\n<div class=\"flex w-full flex-col gap-1 empty:hidden\">\n<div class=\"markdown prose dark:prose-invert w-full wrap-break-word light markdown-new-styling\">\n<p data-start=\"0\" data-end=\"262\"><span class=\"hover:entity-accent entity-underline inline cursor-pointer align-baseline\"><span class=\"whitespace-normal\">Aptamer Group has secured <\/span><\/span>\u00a34.3m in a heavily supported fundraise, as the Yorkshire-based life sciences business looks to accelerate development of its next-generation synthetic binder platform.<\/p>\n<p data-start=\"0\" data-end=\"262\">Alongside the institutional fundraise, Aptamer Group is launching a retail offer to raise up to \u00a30.5m by issuing new ordinary shares at 0.6 pence each, with participants receiving one warrant for every three shares subscribed.<\/p>\n<p data-start=\"264\" data-end=\"581\">The company confirmed it has issued more than 712 million new shares at 0.6p each through a placing and subscription, with strong demand from both existing shareholders and new institutional investors. The move broadens Aptamer\u2019s investor base and strengthens market support at a pivotal stage in its growth strategy.<\/p>\n<p data-start=\"815\" data-end=\"900\">Directors also demonstrated confidence in the business by participating in the raise.<\/p>\n<p data-start=\"902\" data-end=\"1143\">Chief executive Dr Arron Tolley said the funding builds on a stable financial footing outlined in interim results earlier this week, which showed a \u00a31.5m cash position at the end of December 2025 and a runway into the second quarter of 2027.<\/p>\n<p data-start=\"1145\" data-end=\"1302\">He said: \u201cWe are delighted with the strong support we have received\u2026 including from a number of new investors who share our vision for the Optimer\u00ae platform.<\/p>\n<p data-start=\"1304\" data-end=\"1831\">\u201cWith this strong foundation now validated, the \u00a34.275m we have raised today is primarily for growth. A small portion will be allocated to working capital, materially extending our runway to 2028 and providing a clear pathway towards EBITDA breakeven. The majority of the funds will accelerate our two highest-potential opportunities: the development of our AI model focused on RNA-binding proteins and transcription factors, and the generation of key in-vivo animal data for the targeted radiopharmaceutical programme.\u201d<\/p>\n<p data-start=\"1833\" data-end=\"2028\">While a portion of the proceeds will be used for working capital &#8211; extending the company\u2019s financial runway into 2028 &#8211; the bulk is earmarked for growth initiatives aimed at driving commercial value.<\/p>\n<p data-start=\"2030\" data-end=\"2244\">That includes accelerating development of an artificial intelligence model targeting RNA-binding proteins and transcription factors, alongside generating in-vivo data for its targeted radiopharmaceutical programme.<\/p>\n<p data-start=\"2246\" data-end=\"2458\">The dual-track investment signals a sharpened focus on high-potential areas within Aptamer\u2019s pipeline, as it looks to move closer to EBITDA breakeven and unlock further opportunities from its Optimer\u00ae technology.<\/p>\n<p data-start=\"2460\" data-end=\"2728\" data-is-last-node=\"\" data-is-only-node=\"\">The fundraise comes at a time when investor appetite for scalable, platform-led life sciences businesses is returning, particularly those leveraging AI to shorten drug discovery timelines &#8211; placing Aptamer firmly in a competitive and fast-evolving segment of the market.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"z-0 flex min-h-[46px] justify-start\"><\/div>\n<\/div>\n<\/div>\n<\/section>\n<\/div>\n<\/div>\n<div id=\"thread-bottom-container\" class=\"sticky bottom-0 z-10 group\/thread-bottom-container relative isolate w-full basis-auto has-data-has-thread-error:pt-2 has-data-has-thread-error:[box-shadow:var(--sharp-edge-bottom-shadow)] md:border-transparent md:pt-0 dark:border-white\/20 md:dark:border-transparent print:hidden content-fade single-line flex flex-col\">\n<div id=\"thread-bottom\">\n<div class=\"text-base mx-auto [--thread-content-margin:var(--thread-content-margin-xs,calc(var(--spacing)*4))] @w-sm\/main:[--thread-content-margin:var(--thread-content-margin-sm,calc(var(--spacing)*6))] @w-lg\/main:[--thread-content-margin:var(--thread-content-margin-lg,calc(var(--spacing)*16))] px-(--thread-content-margin)\">\n<div class=\"[--thread-content-max-width:40rem] @w-lg\/main:[--thread-content-max-width:48rem] mx-auto max-w-(--thread-content-max-width) flex-1 mb-[var(--thread-component-gap,1rem)]\">\n<div class=\"pointer-events-auto relative z-1 flex h-(--composer-container-height,100%) max-w-full flex-(--composer-container-flex,1) flex-col\">\n<div class=\"\">\n<div class=\"bg-token-bg-primary corner-superellipse\/1.1 cursor-text overflow-clip bg-clip-padding p-2.5 contain-inline-size motion-safe:transition-colors motion-safe:duration-200 motion-safe:ease-in-out dark:bg-[#303030] grid grid-cols-[auto_1fr_auto] [grid-template-areas:'header_header_header'_'leading_primary_trailing'_'._footer_.'] group-data-expanded\/composer:[grid-template-areas:'header_header_header'_'primary_primary_primary'_'leading_footer_trailing'] shadow-short-composer\" data-composer-surface=\"true\">\n<div class=\"flex items-center gap-2 [grid-area:trailing]\">\n<div class=\"ms-auto flex items-center gap-1.5\">\n<div>\n<div class=\"relative\">\n<p data-start=\"73\" data-end=\"220\">\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Fresh funding, new institutional support and a retail offer signal growing confidence in the Yorkshire biotech\u2019s AI-led drug discovery ambitions<\/p>\n","protected":false},"author":271992,"featured_media":2152419,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[53262,120781],"coauthors":[137100],"class_list":["post-2152417","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business-news","category-markets","tag-featured-story","tag-yorkshire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Aptamer lands \u00a34.3m backing as investors double down on growth push | TheBusinessDesk.com<\/title>\n<meta name=\"description\" content=\"Fresh funding, new institutional support and a retail offer signal growing confidence in the Yorkshire biotech\u2019s AI-led drug discovery ambitions\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.thebusinessdesk.com\/yorkshire\/news\/2152417-aptamer-lands-4.3m-backing-as-investors-double-down-on-growth-push\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aptamer lands \u00a34.3m backing as investors double down on growth push | TheBusinessDesk.com\" \/>\n<meta property=\"og:description\" content=\"Fresh funding, new institutional support and a retail offer signal growing confidence in the Yorkshire biotech\u2019s AI-led drug discovery ambitions\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.thebusinessdesk.com\/yorkshire\/news\/2152417-aptamer-lands-4.3m-backing-as-investors-double-down-on-growth-push\" \/>\n<meta property=\"og:site_name\" content=\"Yorkshire\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-26T07:52:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.thebusinessdesk.com\/_files\/images\/mar_26\/Dr-Arron-Tolley-CEO-Aptamer-Group-plc-1-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2362\" \/>\n\t<meta property=\"og:image:height\" content=\"1782\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Sheryl Moore\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sheryl Moore\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.thebusinessdesk.com\/yorkshire\/news\/2152417-aptamer-lands-4.3m-backing-as-investors-double-down-on-growth-push\",\"url\":\"https:\/\/www.thebusinessdesk.com\/yorkshire\/news\/2152417-aptamer-lands-4.3m-backing-as-investors-double-down-on-growth-push\",\"name\":\"Aptamer lands \u00a34.3m backing as investors double down on growth push | TheBusinessDesk.com\",\"isPartOf\":{\"@id\":\"https:\/\/www.thebusinessdesk.com\/yorkshire\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.thebusinessdesk.com\/yorkshire\/news\/2152417-aptamer-lands-4.3m-backing-as-investors-double-down-on-growth-push#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.thebusinessdesk.com\/yorkshire\/news\/2152417-aptamer-lands-4.3m-backing-as-investors-double-down-on-growth-push#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.thebusinessdesk.com\/_files\/images\/mar_26\/Dr-Arron-Tolley-CEO-Aptamer-Group-plc-1-1.jpg\",\"datePublished\":\"2026-03-26T07:52:16+00:00\",\"dateModified\":\"2026-03-26T07:52:16+00:00\",\"author\":{\"@id\":\"https:\/\/www.thebusinessdesk.com\/yorkshire\/#\/schema\/person\/d5e008f7377610b6b95ad01c4a4b1845\"},\"description\":\"Fresh funding, new institutional support and a retail offer signal growing confidence in the Yorkshire biotech\u2019s AI-led drug discovery ambitions\",\"breadcrumb\":{\"@id\":\"https:\/\/www.thebusinessdesk.com\/yorkshire\/news\/2152417-aptamer-lands-4.3m-backing-as-investors-double-down-on-growth-push#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.thebusinessdesk.com\/yorkshire\/news\/2152417-aptamer-lands-4.3m-backing-as-investors-double-down-on-growth-push\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/www.thebusinessdesk.com\/yorkshire\/news\/2152417-aptamer-lands-4.3m-backing-as-investors-double-down-on-growth-push#primaryimage\",\"url\":\"https:\/\/www.thebusinessdesk.com\/_files\/images\/mar_26\/Dr-Arron-Tolley-CEO-Aptamer-Group-plc-1-1.jpg\",\"contentUrl\":\"https:\/\/www.thebusinessdesk.com\/_files\/images\/mar_26\/Dr-Arron-Tolley-CEO-Aptamer-Group-plc-1-1.jpg\",\"width\":2362,\"height\":1782},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.thebusinessdesk.com\/yorkshire\/news\/2152417-aptamer-lands-4.3m-backing-as-investors-double-down-on-growth-push#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.thebusinessdesk.com\/yorkshire\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Aptamer lands \u00a34.3m backing as investors double down on growth push\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.thebusinessdesk.com\/yorkshire\/#website\",\"url\":\"https:\/\/www.thebusinessdesk.com\/yorkshire\/\",\"name\":\"Yorkshire\",\"description\":\"Regional business news for Yorkshire\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.thebusinessdesk.com\/yorkshire\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.thebusinessdesk.com\/yorkshire\/#\/schema\/person\/d5e008f7377610b6b95ad01c4a4b1845\",\"name\":\"Sheryl Moore\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/www.thebusinessdesk.com\/yorkshire\/#\/schema\/person\/image\/30080a04dad1693c9d397756bce5f202\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/535a644f00c4db5101393200c4b44864?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/535a644f00c4db5101393200c4b44864?s=96&d=mm&r=g\",\"caption\":\"Sheryl Moore\"},\"url\":\"https:\/\/www.thebusinessdesk.com\/yorkshire\/news\/author\/sherylmoore\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aptamer lands \u00a34.3m backing as investors double down on growth push | TheBusinessDesk.com","description":"Fresh funding, new institutional support and a retail offer signal growing confidence in the Yorkshire biotech\u2019s AI-led drug discovery ambitions","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.thebusinessdesk.com\/yorkshire\/news\/2152417-aptamer-lands-4.3m-backing-as-investors-double-down-on-growth-push","og_locale":"en_GB","og_type":"article","og_title":"Aptamer lands \u00a34.3m backing as investors double down on growth push | TheBusinessDesk.com","og_description":"Fresh funding, new institutional support and a retail offer signal growing confidence in the Yorkshire biotech\u2019s AI-led drug discovery ambitions","og_url":"https:\/\/www.thebusinessdesk.com\/yorkshire\/news\/2152417-aptamer-lands-4.3m-backing-as-investors-double-down-on-growth-push","og_site_name":"Yorkshire","article_published_time":"2026-03-26T07:52:16+00:00","og_image":[{"width":2362,"height":1782,"url":"https:\/\/www.thebusinessdesk.com\/_files\/images\/mar_26\/Dr-Arron-Tolley-CEO-Aptamer-Group-plc-1-1.jpg","type":"image\/jpeg"}],"author":"Sheryl Moore","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Sheryl Moore","Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.thebusinessdesk.com\/yorkshire\/news\/2152417-aptamer-lands-4.3m-backing-as-investors-double-down-on-growth-push","url":"https:\/\/www.thebusinessdesk.com\/yorkshire\/news\/2152417-aptamer-lands-4.3m-backing-as-investors-double-down-on-growth-push","name":"Aptamer lands \u00a34.3m backing as investors double down on growth push | TheBusinessDesk.com","isPartOf":{"@id":"https:\/\/www.thebusinessdesk.com\/yorkshire\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.thebusinessdesk.com\/yorkshire\/news\/2152417-aptamer-lands-4.3m-backing-as-investors-double-down-on-growth-push#primaryimage"},"image":{"@id":"https:\/\/www.thebusinessdesk.com\/yorkshire\/news\/2152417-aptamer-lands-4.3m-backing-as-investors-double-down-on-growth-push#primaryimage"},"thumbnailUrl":"https:\/\/www.thebusinessdesk.com\/_files\/images\/mar_26\/Dr-Arron-Tolley-CEO-Aptamer-Group-plc-1-1.jpg","datePublished":"2026-03-26T07:52:16+00:00","dateModified":"2026-03-26T07:52:16+00:00","author":{"@id":"https:\/\/www.thebusinessdesk.com\/yorkshire\/#\/schema\/person\/d5e008f7377610b6b95ad01c4a4b1845"},"description":"Fresh funding, new institutional support and a retail offer signal growing confidence in the Yorkshire biotech\u2019s AI-led drug discovery ambitions","breadcrumb":{"@id":"https:\/\/www.thebusinessdesk.com\/yorkshire\/news\/2152417-aptamer-lands-4.3m-backing-as-investors-double-down-on-growth-push#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.thebusinessdesk.com\/yorkshire\/news\/2152417-aptamer-lands-4.3m-backing-as-investors-double-down-on-growth-push"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.thebusinessdesk.com\/yorkshire\/news\/2152417-aptamer-lands-4.3m-backing-as-investors-double-down-on-growth-push#primaryimage","url":"https:\/\/www.thebusinessdesk.com\/_files\/images\/mar_26\/Dr-Arron-Tolley-CEO-Aptamer-Group-plc-1-1.jpg","contentUrl":"https:\/\/www.thebusinessdesk.com\/_files\/images\/mar_26\/Dr-Arron-Tolley-CEO-Aptamer-Group-plc-1-1.jpg","width":2362,"height":1782},{"@type":"BreadcrumbList","@id":"https:\/\/www.thebusinessdesk.com\/yorkshire\/news\/2152417-aptamer-lands-4.3m-backing-as-investors-double-down-on-growth-push#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.thebusinessdesk.com\/yorkshire\/"},{"@type":"ListItem","position":2,"name":"Aptamer lands \u00a34.3m backing as investors double down on growth push"}]},{"@type":"WebSite","@id":"https:\/\/www.thebusinessdesk.com\/yorkshire\/#website","url":"https:\/\/www.thebusinessdesk.com\/yorkshire\/","name":"Yorkshire","description":"Regional business news for Yorkshire","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.thebusinessdesk.com\/yorkshire\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/www.thebusinessdesk.com\/yorkshire\/#\/schema\/person\/d5e008f7377610b6b95ad01c4a4b1845","name":"Sheryl Moore","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.thebusinessdesk.com\/yorkshire\/#\/schema\/person\/image\/30080a04dad1693c9d397756bce5f202","url":"https:\/\/secure.gravatar.com\/avatar\/535a644f00c4db5101393200c4b44864?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/535a644f00c4db5101393200c4b44864?s=96&d=mm&r=g","caption":"Sheryl Moore"},"url":"https:\/\/www.thebusinessdesk.com\/yorkshire\/news\/author\/sherylmoore"}]}},"_links":{"self":[{"href":"https:\/\/www.thebusinessdesk.com\/yorkshire\/wp-json\/wp\/v2\/posts\/2152417","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.thebusinessdesk.com\/yorkshire\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.thebusinessdesk.com\/yorkshire\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.thebusinessdesk.com\/yorkshire\/wp-json\/wp\/v2\/users\/271992"}],"replies":[{"embeddable":true,"href":"https:\/\/www.thebusinessdesk.com\/yorkshire\/wp-json\/wp\/v2\/comments?post=2152417"}],"version-history":[{"count":1,"href":"https:\/\/www.thebusinessdesk.com\/yorkshire\/wp-json\/wp\/v2\/posts\/2152417\/revisions"}],"predecessor-version":[{"id":2152420,"href":"https:\/\/www.thebusinessdesk.com\/yorkshire\/wp-json\/wp\/v2\/posts\/2152417\/revisions\/2152420"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.thebusinessdesk.com\/yorkshire\/wp-json\/wp\/v2\/media\/2152419"}],"wp:attachment":[{"href":"https:\/\/www.thebusinessdesk.com\/yorkshire\/wp-json\/wp\/v2\/media?parent=2152417"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.thebusinessdesk.com\/yorkshire\/wp-json\/wp\/v2\/categories?post=2152417"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/www.thebusinessdesk.com\/yorkshire\/wp-json\/wp\/v2\/coauthors?post=2152417"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}